SAN MATEO, Calif., April 16, 2019 – Evidation Health, a health and measurement company that helps innovative life sciences and health care companies understand how everyday behaviors and health interact, announced the results of a study that found individuals who tracked their activity through wearables and connected apps were 1.3 times more likely to adhere to their medication regimen for chronic conditions.
The study also demonstrated a positive association between the frequency of activity tracking and medication adherence. Specifically, the authors found that medication adherence improves as the consistency of tracker use and activity levels increase. In other words, among those who use activity trackers, those who track more often are more likely to be adherent to their medications, and those who are more active are also more likely to be adherent.
“It’s encouraging to see this strong relationship between activity tracking and medication adherence as the health care system seeks to improve health outcomes and lower costs,” said principal investigator Jessie Juusola, Ph.D., Evidation’s senior director of health outcomes research. “This signals that everyday behavior data from activity tracking may be a useful tool for identifying individuals who could benefit from medication adherence programs.”
The study, published in the Journal of Medical Internet Research, leveraged medical and pharmacy claims and other health behavior data from Humana-insured individuals to examine how medication adherence differed among large populations with hypertension, diabetes, and dyslipidemia, comparing those who tracked activity with those who did not.
In the retrospective analysis, Evidation paired deidentified claims from Humana with digital health activity data from more than 8,500 individuals who used trackers made by companies including Apple, Fitbit, Garmin, and Jawbone. This subgroup of individuals who had health behavior data available was taken from a larger dataset of 117,000 people with diabetes, 317,000 with dyslipidemia, and 673,000 with hypertension. Individuals tracked step counts, sleep, weight, and nutrition, with step counts being the most common. Researchers controlled for age and sex to demonstrate the statistically significant relationship between medication adherence (as measured by the proportion of days covered, PDC) and activity tracking in individuals with chronic conditions.
Prescription medication adherence has historically been low for individuals with chronic diseases, though improving adherence leads to better health outcomes and lower total care costs. Before this study, the relationship between medication adherence and health activity behavior had not been explored extensively. Better understanding of the link between behavior and medication adherence could lead to more programs and approaches to improve adherence and lower disease burden.
The study was supported by Evidation’s Andromeda data platform, which enables large-scale behavior data from smartphones, wearables, and connected sensors to be analyzed and processed in clinically meaningful ways.
Evidation Health is a new kind of health and measurement company that provides the world’s most innovative life sciences and health care companies the technology and expertise they need to understand how everyday behavior and health interact. The volume of behavior data generated from smartphones and connected sensors — including wearables and medical devices — has opened up new ways to analyze individuals’ behavior and health in real time, unlocking insights into what medicines and treatments work best and spotting significant changes in health earlier. The scale and utility of everyday behavior data has the potential to be one of the most transformative forces in medicine, and Evidation Health is leading the way.
Over the years, Evidation has built the largest, most diverse virtual pool of research participants through its proprietary and popular app, Achievement. With a direct and trusted relationship with more than 2 million individuals, its deep research expertise, and its data platform, Evidation can undertake real world research for life sciences and health care companies — and, ultimately, transform how health is measured and how diseases are identified, treated, and monitored. Founded in 2012, Evidation Health is headquartered in San Mateo, Calif., with additional offices in San Francisco and Santa Barbara, Calif. To learn more, visit evidation.com, or follow us on Twitter @evidation.